How to approach and treat VAP in ICU patients BMC Infectious Diseases Springer Nature Link VAP Prevention in the CTICU Ventilator associated pneumonia in adults: a narrative review Intensive Care Medicine Springer Nature Link Pharma's New Frontier How the VAP Market is Shaping the Future of Critical Care Ventilator associated pneumonia in the era of COVID 19 pandemic: How common and what is the impact? Critical Care Springer Nature Link The Challenge. The Evidence. The Solution. Ventilator Associated Pneumonia (VAP) remains a serious clinical issue in UK ICUs with NHS England data estimating 3,0006,000 deaths per year and treatment costs of 10,00020,000